Anifrolumab Treatment Prevents Long-Term Oral Corticosteroid-Related, Ocular, and Musculoskeletal Organ Damage Accrual Compared With Real-World Standard of Care in Patients With Systemic Lupus Erythematosus: Findings From the LASER Study (ACR Convergence 2026) - Sep 8, 2026 - Abstract #2192; Pres time: Nov 10, 2026; 10:30 AM - 12:30 PM; Location: WB1&2; In Person; No abstract available
Clinical • Real-world • Real-world evidence • Immunology • Inflammatory Arthritis • Lupus • Musculoskeletal Diseases • Systemic Lupus Erythematosus
|